CrushSCI.com
Journal Selection & Manuscript Polishing Services
Human Vaccines & Immunotherapeutics journal cover Medicine
Back to journal directory

Review Cycle Records

Human Vaccines & Immunotherapeutics

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
114.5Average days
107Median days
67Fastest days
189Longest days
5482025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

67 days

Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study

AuthorsYumeng Gao; Nannan Wu; Suwen Shen; Xiaowei Zheng; Yujun Chen; Chao Shi

Affiliations1. The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi Center for Disease Control and Prevention; 2. Suzhou Industrial Park Medical and Health Management Center; 3. Wuxi School of Medicine Jiangnan University

Source PDF DOI Publisher page
86 days

Cost-effectiveness analysis of disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing advanced urothelial cancer

AuthorsZuojuan Xiang; Zhengxiong Li

Affiliations1. Central South University, Hunan Cancer Hospital; 2. Xuzhou Medical University

Source PDF DOI Publisher page
107 days

“As soon as it’s trying to be persuasive, my skepticism kicks in”: A qualitative study to co-design vaccine communication strategies with vaccine hesitant adults in Canada

AuthorsJeanna Parsons Leigh; Stephana Julia Moss; Jade MacDonald; Cristina Zuniga Chacon; Sara J. Mizen; Henry T. Stelfox; Ève Dubé; Kirsten M. Fiest; Donna M. Halperin; Sofia B. Ahmed; Shannon E. MacDonald; Sharon E. Straus; Terra Manca; Josh Ng Kamstra; Andrea Soo; Scott A. Halperin

Affiliations1. Dalhousie University; 2. Canadian Center for Vaccinology & IWK Health Center; 3. University of Calgary; 4. University of Alberta; 5. Université Laval; 6. St. Francis Xavier University; 7. Unity Health Toronto; 8. University of Toronto; 9. Athabasca University; 10. Massachusetts General Hospital and Harvard Medical School; 11. Health Shared Services

Source PDF DOI Publisher page
77 days

Pneumococcal vaccination status in critically ill patients: A cross-sectional study

AuthorsTatsuya Watanabe; Hidehiko Nakano; Maiko Motoki; Yuji Wakimoto; Daisuke Ikechi; Masaki Mochizuki; Yuji Takahashi; Yasuaki Koyama; Hideki Hashimoto

Affiliations1. Hitachi General Hospital; 2. University of Tsukuba Hospital

Source PDF DOI Publisher page
189 days

The current role of immunotherapy in treating nasopharyngeal carcinoma

AuthorsLin-Feng Guo; Min-Jia Sun; Shu-Yao Li; San-Gang Wu

Affiliations1. Xiamen University; 2. Sun Yat-sen University Shenzhen Campus, Sun Yat-Sen University

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.